MCCN Stock Overview
Medcolcanna Organics Inc. operates as a medical cannabis company in Colombia and Switzerland.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Medcolcanna Organics Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.005 |
| 52 Week High | CA$0.08 |
| 52 Week Low | CA$0.005 |
| Beta | 1.22 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -93.75% |
| 3 Year Change | -95.83% |
| 5 Year Change | n/a |
| Change since IPO | -98.21% |
Recent News & Updates
Recent updates
Shareholder Returns
| MCCN | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | -1.8% | -0.6% |
| 1Y | -93.8% | 50.8% | 3.9% |
Return vs Industry: MCCN underperformed the Canadian Pharmaceuticals industry which returned -29.5% over the past year.
Return vs Market: MCCN underperformed the Canadian Market which returned -0.7% over the past year.
Price Volatility
| MCCN volatility | |
|---|---|
| MCCN Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 13.9% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.3% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: MCCN has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MCCN's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 90 | Felipe De La Vega | medcolcanna.com |
Medcolcanna Organics Inc. operates as a medical cannabis company in Colombia and Switzerland. The company cultivates, produces, and distributes medicinal cannabis and cannabis derived products, including pharmaceutical, cosmetic, and bulk API products. Medcolcanna Organics Inc. is based in Calgary, Canada.
Medcolcanna Organics Inc. Fundamentals Summary
| MCCN fundamental statistics | |
|---|---|
| Market cap | CA$848.69k |
| Earnings (TTM) | -CA$6.35m |
| Revenue (TTM) | CA$316.61k |
2.7x
P/S Ratio-0.1x
P/E RatioIs MCCN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MCCN income statement (TTM) | |
|---|---|
| Revenue | CA$316.61k |
| Cost of Revenue | CA$1.95m |
| Gross Profit | -CA$1.63m |
| Other Expenses | CA$4.73m |
| Earnings | -CA$6.35m |
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.037 |
| Gross Margin | -514.55% |
| Net Profit Margin | -2,007.02% |
| Debt/Equity Ratio | -102.1% |
How did MCCN perform over the long term?
See historical performance and comparison